Some Drugs and Herbal Products
Publisher: International Agency for Research on Cancer 2016
Number of pages: 438
This volume of the IARC Monographs provides an assessment of the carcinogenicity of 14 drugs and herbal products. The authors relied on epidemiological studies to evaluate the carcinogenic hazard to humans exposed to the drugs digoxin (widely prescribed for the treatment of chronic heart failure), pioglitazone (used for the treatment of type 2 diabetes mellitus), and hydrochlorothiazide (used to treat hypertension).
Home page url
Download or read it online for free here:
by Howard P. Greenwald - University of California Press
Addressed to health-care professionals and policymakers, this book makes it clear that we are not winning the war against cancer. The author looks at how class, race, sex, and available treatments can affect one's chances of survival.
- International Agency for Research on Cancer
This volume Evaluates the carcinogenic risk to humans posed by infection with three schistosoma trematodes, three liver flukes and Helicobacter pylori, selected on the basis of a causal association between infection and the development of cancers.
by James F. Holland, at al. - B.C. Decker
A reference source for medical oncologists, radiation oncologists, internists, surgical oncologists, and others who treat cancer patients. The book covers the ever-widening sphere of current cancer knowledge and clinical practice.
by William H. Ward, Jeffrey M. Farma (eds) - Codon Publications
The book provides an overview of the epidemiology, pathology, and evidence-based treatment options for patients with all stages of melanoma. These aspects are presented in two sections: epidemiology and pathophysiology, and therapy and management.